Simplex Trading’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Simplex Trading’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-40,100	Closed	-$104K	–	12013
2021 Q3	$104K	Buy	40,100 +3,300	+9%	+$114K	﹤0.01%	6579
2021 Q2	$1.01M	Buy	36,800 +36,607	+18,967%	+$719K	﹤0.01%	3101
2021 Q1	$318K	Buy	193 +68	+54%	+$1.55K	﹤0.01%	4081
2020 Q4	$230K	Sell	125 -91	-42%	-$1.63K	﹤0.01%	4415
2020 Q3	$293K	Buy	216 +179	+484%	+$2.76K	﹤0.01%	3632
2020 Q2	$66K	Buy	+37	New	+$558	﹤0.01%	5239

Simplex Trading's TBIO Position: Q1 2021 in Review

Simplex Trading sold out of Translate Bio, Inc. Common Stock (TBIO) in Q1 2021, closing a stake of 13,834 shares — an estimated $315K sold.

Simplex Trading first reported a position in TBIO in Q2 2020 and held it in 3 quarters. The position peaked at $399K in Q2 2020. 146 funds tracked by Wall St. Rank hold TBIO as of Q1 2021.

Simplex Trading reported no remaining Translate Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Simplex Trading sold 13,834 Translate Bio, Inc. Common Stock shares in Q1 2021, an estimated $315K.
Simplex Trading first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
Simplex Trading's Translate Bio, Inc. Common Stock position peaked at $399K in Q2 2020.
146 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q1 2021.

Based on Simplex Trading's 13F filing for Q1 2021, filed 26 Apr 2021.